Home

belső gerenda Felszerelés abl protein Előrelátás Bűnbánat Keménység

BCR-ABL: Protein Structure and Function
BCR-ABL: Protein Structure and Function

Disabling Abl—Perspectives on Abl kinase regulation and cancer  therapeutics: Cancer Cell
Disabling Abl—Perspectives on Abl kinase regulation and cancer therapeutics: Cancer Cell

Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition  and the metastatic cascade | Cell Communication and Signaling | Full Text
Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade | Cell Communication and Signaling | Full Text

Cytoplasmic signalling by the câ•'Abl tyrosine kinase in normal and cancer  cells
Cytoplasmic signalling by the câ•'Abl tyrosine kinase in normal and cancer cells

Bcr-Abl and Imatinib (STI571 or Gleevec) - Proteopedia, life in 3D
Bcr-Abl and Imatinib (STI571 or Gleevec) - Proteopedia, life in 3D

Structure of the Abl protein: The 145 kDa Abl protein has two isoforms....  | Download Scientific Diagram
Structure of the Abl protein: The 145 kDa Abl protein has two isoforms.... | Download Scientific Diagram

The Capable ABL: What Is Its Biological Function? | Molecular and Cellular  Biology
The Capable ABL: What Is Its Biological Function? | Molecular and Cellular Biology

Abl Oncogenes (Molecular Biology)
Abl Oncogenes (Molecular Biology)

Interplay between Kinase Domain Autophosphorylation and F-Actin Binding  Domain in Regulating Imatinib Sensitivity and Nuclear Import of BCR-ABL |  PLOS ONE
Interplay between Kinase Domain Autophosphorylation and F-Actin Binding Domain in Regulating Imatinib Sensitivity and Nuclear Import of BCR-ABL | PLOS ONE

BCR ABL Protein - an overview | ScienceDirect Topics
BCR ABL Protein - an overview | ScienceDirect Topics

IJMS | Free Full-Text | Blockade of Y177 and Nuclear Translocation of Bcr- Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid  Leukemia Cells
IJMS | Free Full-Text | Blockade of Y177 and Nuclear Translocation of Bcr- Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells

Regulatory Molecules and Corresponding Processes of BCR-ABL Protein  Degradation
Regulatory Molecules and Corresponding Processes of BCR-ABL Protein Degradation

Differential signaling networks of Bcr–Abl p210 and p190 kinases in  leukemia cells defined by functional proteomics | Leukemia
Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia

Structure and Dynamic Regulation of Abl Kinases* - ScienceDirect
Structure and Dynamic Regulation of Abl Kinases* - ScienceDirect

Autophagic degradation determines the fate of T315I-mutated BCR-ABL protein  | Haematologica
Autophagic degradation determines the fate of T315I-mutated BCR-ABL protein | Haematologica

The Capable ABL: What Is Its Biological Function? | Molecular and Cellular  Biology
The Capable ABL: What Is Its Biological Function? | Molecular and Cellular Biology

Is the fusion Bcr-Abl protein the same thing as Abl kinase? - The Student  Room
Is the fusion Bcr-Abl protein the same thing as Abl kinase? - The Student Room

Frontiers | BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid  Leukemia
Frontiers | BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia

ABL (gene) - Wikipedia
ABL (gene) - Wikipedia

PDF] Molecular Pathways: BCR-ABL | Semantic Scholar
PDF] Molecular Pathways: BCR-ABL | Semantic Scholar

Differential signaling networks of Bcr–Abl p210 and p190 kinases in  leukemia cells defined by functional proteomics | Leukemia
Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia

Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis: Cell
Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis: Cell

BCR/ABL inhibition by an escort/phosphatase fusion protein | PNAS
BCR/ABL inhibition by an escort/phosphatase fusion protein | PNAS

Tyrosine-kinase inhibition in treatment of chronic myeloid leukaemia - The  Lancet
Tyrosine-kinase inhibition in treatment of chronic myeloid leukaemia - The Lancet

NEJM -- Chronic Myeloid Leukemia -- Advances in Biology and New Approaches  to Treatment -- Figure 2
NEJM -- Chronic Myeloid Leukemia -- Advances in Biology and New Approaches to Treatment -- Figure 2

PF‑114, a novel selective inhibitor of BCR‑ABL tyrosine kinase, is a potent  inducer of apoptosis in chronic myelogenous leukemia cells
PF‑114, a novel selective inhibitor of BCR‑ABL tyrosine kinase, is a potent inducer of apoptosis in chronic myelogenous leukemia cells

Flying under the radar: the new wave of BCR–ABL inhibitors | Nature Reviews  Drug Discovery
Flying under the radar: the new wave of BCR–ABL inhibitors | Nature Reviews Drug Discovery